200 related articles for article (PubMed ID: 32973297)
1. Vitreous levels of interleukin-35 as a prognostic factor in B-cell vitreoretinal lymphoma.
Takeda A; Hasegawa E; Nakao S; Ishikawa K; Murakami Y; Hisatomi T; Arima M; Yawata N; Oda Y; Kimura K; Yoshikawa H; Sonoda KH
Sci Rep; 2020 Sep; 10(1):15715. PubMed ID: 32973297
[TBL] [Abstract][Full Text] [Related]
2. Distinct Profiles of Soluble Cytokine Receptors Between B-Cell Vitreoretinal Lymphoma and Uveitis.
Takeda A; Yoshikawa H; Fukuhara T; Hikita S; Hijioka K; Otomo T; Arita R; Hisatomi T; Kimura K; Yoshida S; Kawano Y; Sonoda KH; Ishibashi T
Invest Ophthalmol Vis Sci; 2015 Nov; 56(12):7516-23. PubMed ID: 26595610
[TBL] [Abstract][Full Text] [Related]
3. Combined cellular and soluble mediator analysis for improved diagnosis of vitreoretinal lymphoma.
de Hoog J; Dik WA; Lu L; Heezen KC; Ten Berge JC; Swagemakers SMA; van der Spek PJ; van Dongen JJM; van der Velden VHJ; Rothova A; Langerak AW
Acta Ophthalmol; 2019 Sep; 97(6):626-632. PubMed ID: 30688042
[TBL] [Abstract][Full Text] [Related]
4. Potential Diagnosis of Vitreoretinal Lymphoma by Detection of MYD88 Mutation in Aqueous Humor With Ultrasensitive Droplet Digital Polymerase Chain Reaction.
Hiemcke-Jiwa LS; Ten Dam-van Loon NH; Leguit RJ; Nierkens S; Ossewaarde-van Norel J; de Boer JH; Roholl FF; de Weger RA; Huibers MMH; de Groot-Mijnes JDF; Kuiper JJW
JAMA Ophthalmol; 2018 Oct; 136(10):1098-1104. PubMed ID: 30027272
[TBL] [Abstract][Full Text] [Related]
5. DIFFERENTIAL DIAGNOSIS FOR VITREORETINAL LYMPHOMA WITH VITREORETINAL FINDINGS, IMMUNOGLOBULIN CLONALITY TESTS, AND INTERLEUKIN LEVELS.
Lee J; Kim SW; Kim H; Lee CS; Kim M; Lee SC
Retina; 2019 Jun; 39(6):1165-1176. PubMed ID: 29474309
[TBL] [Abstract][Full Text] [Related]
6. Immune mediators in vitreous fluids from patients with vitreoretinal B-cell lymphoma.
Usui Y; Wakabayashi Y; Okunuki Y; Kimura K; Tajima K; Matsuda R; Ueda S; Ma J; Nagai T; Mori H; Kezuka T; Nagao T; Goto H
Invest Ophthalmol Vis Sci; 2012 Aug; 53(9):5395-402. PubMed ID: 22789925
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic efficacy of cell block method for vitreoretinal lymphoma.
Kase S; Namba K; Iwata D; Mizuuchi K; Kitaichi N; Tagawa Y; Okada-Kanno H; Matsuno Y; Ishida S
Diagn Pathol; 2016 Mar; 11():29. PubMed ID: 26987877
[TBL] [Abstract][Full Text] [Related]
8. USE OF A THRESHOLD OF INTERLEUKIN-10 AND IL-10/IL-6 RATIO IN OCULAR SAMPLES FOR THE SCREENING OF VITREORETINAL LYMPHOMA.
Pochat-Cotilloux C; Bienvenu J; Nguyen AM; Ohanessian R; Ghesquières H; Sève P; Garnier L; Kodjikian L
Retina; 2018 Apr; 38(4):773-781. PubMed ID: 29135797
[TBL] [Abstract][Full Text] [Related]
9. Role of systemic high-dose methotrexate and combined approaches in the management of vitreoretinal lymphoma: A single center experience 1990-2018.
Castellino A; Pulido JS; Johnston PB; Ristow KM; Nora Bennani N; Inwards DJ; Macon WR; Micallef INM; King RL; Salomao DR; Witzig TE; Habermann TM; Nowakowski GS
Am J Hematol; 2019 Mar; 94(3):291-298. PubMed ID: 30516868
[TBL] [Abstract][Full Text] [Related]
10. Vitreoretinal lymphomas misdiagnosed as uveitis: Lessons learned from a case series.
Cimino L; Coassin M; Chan CC; Marchi S; Belpoliti M; Fanti A; Iovieno A; Fontana L
Indian J Ophthalmol; 2016 May; 64(5):369-75. PubMed ID: 27380976
[TBL] [Abstract][Full Text] [Related]
11. Vitreous Humor Proteomic Profile in Patients With Vitreoretinal Lymphoma.
Komatsu H; Usui Y; Tsubota K; Fujii R; Yamaguchi T; Maruyama K; Wakita R; Asakage M; Hamada K; Yamakawa N; Nezu N; Ueda K; Goto H
Invest Ophthalmol Vis Sci; 2023 Dec; 64(15):2. PubMed ID: 38038618
[TBL] [Abstract][Full Text] [Related]
12. Logistic regression models of cytokines in differentiating vitreoretinal lymphoma from uveitis.
Tian S; Chen K; Xiao J; Zhou X; Shi H; Li Y; Huang H; Ma Y; Chen B; Wang Q; Guan M
J Clin Lab Anal; 2022 Oct; 36(10):e24689. PubMed ID: 36098043
[TBL] [Abstract][Full Text] [Related]
13. The diagnostic value of IL-10 and IL-6 level in vitreous fluid and aqueous humor for vitreoretinal lymphoma.
Chen K; Li X; Wang D; Ma Y; Chen B; Wang Q; Ma J; Guan M
Clin Chim Acta; 2021 Apr; 515():21-26. PubMed ID: 33387464
[TBL] [Abstract][Full Text] [Related]
14. Next generation sequencing of vitreoretinal lymphomas from small-volume intraocular liquid biopsies: new routes to targeted therapies.
Cani AK; Hovelson DH; Demirci H; Johnson MW; Tomlins SA; Rao RC
Oncotarget; 2017 Jan; 8(5):7989-7998. PubMed ID: 28002793
[TBL] [Abstract][Full Text] [Related]
15. Changes in choroidal vascular structure from vitreoretinal lymphoma and the intraocular cytokine level associated with clinical resolution after intravitreal methotrexate treatment.
Kim RY; Park JH; Kim M; Park YG; Cho SG; Park YH
PLoS One; 2021; 16(11):e0260469. PubMed ID: 34813633
[TBL] [Abstract][Full Text] [Related]
16. More than a masquerade syndrome: atypical presentations of vitreoretinal lymphomas.
AlQahtani A; Touitou V; Cassoux N; Aknin C; Merle-Beral H; Bodaghi B; LeHoang P
Ocul Immunol Inflamm; 2014 Jun; 22(3):189-96. PubMed ID: 24475870
[TBL] [Abstract][Full Text] [Related]
17. Characteristics of Vitreoretinal Lymphoma in B-Scan Ultrasonography: A Case-Control Study.
Gu J; Chen Q; Zhang P; Zhang T; Zhou X; Zhang K; Jiang T; Liu S; Chen W; Zhou M; Jiang R; Huang X; Xu G; Chang Q
Ophthalmol Retina; 2024 Mar; 8(3):264-269. PubMed ID: 37820767
[TBL] [Abstract][Full Text] [Related]
18. APRIL and BAFF play a key role in differentiating vitreoretinal lymphoma from uveitis.
Tian S; Chen K; Xiao J; Wang D; Zhou X; Li X; Shi H; Li Y; Cao X; Guan M; Chen B; Wang Q
Clin Chim Acta; 2022 Oct; 535():1-6. PubMed ID: 35820532
[TBL] [Abstract][Full Text] [Related]
19. Clinical Features Predictive of Survival in Patients With Vitreoretinal Lymphoma: Analysis of 70 Patients at a Single Ocular Oncology Center.
Dalvin LA; Lim LS; Ancona-Lezama D; Mazloumi M; Chang M; Porcu P; Martinez NL; Glass J; Mashayekhi A; Shields CL
Asia Pac J Ophthalmol (Phila); 2020; 9(2):110-116. PubMed ID: 31923035
[TBL] [Abstract][Full Text] [Related]
20. Aurora borealis and string of pearls in vitreoretinal lymphoma: patterns of vitreous haze.
Marchese A; Miserocchi E; Giuffrè C; Cicinelli MV; Querques G; Bandello F; Modorati G
Br J Ophthalmol; 2019 Nov; 103(11):1656-1659. PubMed ID: 30709808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
